Most Recent Articles
Donations Fuel Lifesaving Work
Published on
Since our founding, Children’s Hospital of Philadelphia has made it our mission to care for vulnerable patients during trying times. Today — more than ever — we see grateful supporters working diligently to help us fulfill that mission.
Video Visits Soar
Published on
The numbers are extraordinary: In the first week of its COVID-19 response, Children’s Hospital of Philadelphia conducted more video visits than in the previous three years combined.
With Poise And Grace: Caring for the sickest children in the strangest times
Published on
Since the advent of COVID-19, a priority at Children’s Hospital has been determining how to manage incoming patients who are seriously ill with other conditions, while maintaining the safety of all — patients, families and staff.
On the Heels of COVID-19 Comes a New Illness – and a New Challenge for CHOP Researchers
Published on
Understanding the biology of both COVID-19 illness and MIS-C will enable scientists to develop much more specific diagnostic tests and help clinicians identify children who are at risk.
An Hour Changes a Life
Published on
New treatments put the brakes on an often-fatal degenerative muscle disease.
Brand-New Dimensions
Published on
3D printed models create exciting possibilities for surgeons and trainees.
How can we protect teens from vaping?
Published on
Louis Bell, MD, Chief of the Division of General Pediatrics, shares the latest in medical thinking on an important topic: e-cigarettes.
Driven by a Commitment to Help Children
Published on
Since 1986, the Auto Dealers Association of Greater Philadelphia (ADAGP) and its entities have donated $8.7 million to CHOP.
Programmed to Charm
Published on
It sings. It dances. It shakes kids’ hands and says their names. Meet NAO (pronounced “now”), a 2-foot-tall robot that has wowed dozens of CHOP patients and families with its intelligence and charm.
Crushing Peanut Allergies
Published on
Palforzia TM is a new oral immunotherapy recently approved by the U.S. Food and Drug Administration to treat children with peanut allergies. The medication involves a daily controlled amount of peanut protein designed to desensitize children and reduce the severity of allergic reactions, some of which can be life-threatening.